(19)
(11) EP 4 445 327 A1

(12)

(43) Date of publication:
16.10.2024 Bulletin 2024/42

(21) Application number: 22905192.5

(22) Date of filing: 09.12.2022
(51) International Patent Classification (IPC): 
G06T 7/00(2017.01)
G06T 7/90(2017.01)
G06T 7/246(2017.01)
G16B 25/10(2019.01)
(52) Cooperative Patent Classification (CPC):
G16B 40/10; G06T 7/11; G06T 2207/10056; G06T 2207/30024
(86) International application number:
PCT/US2022/052449
(87) International publication number:
WO 2023/107720 (15.06.2023 Gazette 2023/24)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 10.12.2021 US 202117547602
04.03.2022 US 202263316784 P
04.03.2022 US 202263316790 P
20.04.2022 US 202217725042
20.04.2022 US 202217725065
06.06.2022 US 202263349421 P
30.06.2022 US 202217854042

(71) Applicant: Element Biosciences, Inc.
San Diego, California 92121 (US)

(72) Inventors:
  • ZHOU, Chunhong
    San Diego, California 92121 (US)
  • KRUGLYAK, Semyon
    San Diego, California 92121 (US)
  • GARCIA, Francisco
    San Diego, California 92121 (US)
  • GUO, Minghao
    San Diego, California 92121 (US)
  • WANG, Haosen
    San Diego, California 92121 (US)
  • KELLY, Ryan
    San Diego, California 92121 (US)

(74) Representative: Vossius & Partner Patentanwälte Rechtsanwälte mbB 
Siebertstraße 3
81675 München
81675 München (DE)

   


(54) PRIMARY ANALYSIS IN NEXT GENERATION SEQUENCING